Found: 63
Select item for more details and to access through your institution.
Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5570, doi. 10.1002/alz.14068
- By:
- Publication type:
- Article
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5143, doi. 10.1002/alz.13859
- By:
- Publication type:
- Article
Primary Care Screening for Dementia and Mild Cognitive Impairment.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome.
- Published in:
- Developmental Neurobiology (19328451), 2019, v. 79, n. 7, p. 711, doi. 10.1002/dneu.22658
- By:
- Publication type:
- Article
Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative.
- Published in:
- Neurodegenerative Diseases, 2018, v. 18, n. 4, p. 173, doi. 10.1159/000488780
- By:
- Publication type:
- Article
Neuropsychiatric Symptoms and Regional Neocortical Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Neuropsychiatric Symptoms and Regional Neocortical Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2014, v. 29, n. 2, p. 159, doi. 10.1177/1533317513507373
- By:
- Publication type:
- Article
From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024, v. 16, n. 2, p. 1, doi. 10.1002/dad2.12580
- By:
- Publication type:
- Article
Safety and tolerability of lumbar puncture for the evaluation of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 2, p. 1, doi. 10.1002/dad2.12431
- By:
- Publication type:
- Article
Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12199
- By:
- Publication type:
- Article
ACI‐24 vaccine in adults with Down syndrome: Human: Putative therapeutic results for Alzheimer's and related dementias.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038678
- By:
- Publication type:
- Article
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 5, p. 797, doi. 10.1002/alz.12058
- By:
- Publication type:
- Article
DT‐02‐03: OPEN LABEL EXTENSION RESULTS FROM A PHASE II/III TRIAL OF INTRANASAL INSULIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1489, doi. 10.1016/j.jalz.2019.08.012
- By:
- Publication type:
- Article
P3‐014: DEEP LEARNING IN AUTOMATED CLASSIFICATION OF ADVERSE EVENTS IN CLINICAL STUDIES OF ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1067, doi. 10.1016/j.jalz.2018.06.1369
- By:
- Publication type:
- Article
P2‐571: A STEP FORWARD IN INTEGRATING HEALTHCARE AND VOICE‐ENABLED TECHNOLOGY: CONCEPT DEMONSTRATION WITH DEPLOYMENT OF AUTOMATIC MEDICAL CODING MODEL AS AN AMAZON "ALEXA" SKILL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P955, doi. 10.1016/j.jalz.2018.06.1266
- By:
- Publication type:
- Article
P1‐345: CLASSIFICATION OF EMOTIONAL RESPONSES IN VIDEO AND AUDIO RECORDINGS USING A CONVOLUTIONAL NEURAL NETWORK.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P426, doi. 10.1016/j.jalz.2018.06.352
- By:
- Publication type:
- Article
TD‐P‐016: DEEP LEARNING IN AUTOMATED CLASSIFICATION OF ADVERSE EVENTS IN CLINICAL STUDIES OF ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P193, doi. 10.1016/j.jalz.2018.06.2032
- By:
- Publication type:
- Article
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, n. 11, p. 1251, doi. 10.1016/j.jalz.2017.03.007
- By:
- Publication type:
- Article
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 5, p. 571, doi. 10.1016/j.jalz.2013.09.004
- By:
- Publication type:
- Article
De novo variants in immune regulatory genes in Down syndrome regression disorder.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 5567, doi. 10.1007/s00415-024-12521-y
- By:
- Publication type:
- Article
Neurologic complications of Down syndrome: a systematic review.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 12, p. 4495, doi. 10.1007/s00415-020-10179-w
- By:
- Publication type:
- Article
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 4, p. 1034, doi. 10.1002/acn3.52023
- By:
- Publication type:
- Article
Hypovitaminosis D in persons with Down syndrome and autism spectrum disorder.
- Published in:
- Journal of Neurodevelopmental Disorders, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s11689-023-09503-y
- By:
- Publication type:
- Article
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder.
- Published in:
- Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09446-w
- By:
- Publication type:
- Article
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group.
- Published in:
- Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09435-z
- By:
- Publication type:
- Article
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.
- Published in:
- Frontiers in Computational Neuroscience, 2015, p. 1, doi. 10.3389/fnbeh.2015.00239
- By:
- Publication type:
- Article
Predicting the course of Alzheimer’s progression.
- Published in:
- Brain Informatics, 2019, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40708-019-0099-0
- By:
- Publication type:
- Article
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.
- Published in:
- Frontiers in Behavioral Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fnbeh.2015.00239
- By:
- Publication type:
- Article
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.
- Published in:
- Frontiers in Behavioral Neuroscience, 2015, p. 1, doi. 10.3389/fnbeh.2015.00239
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 6, p. 565, doi. 10.1001/jamaneurol.2022.0983
- By:
- Publication type:
- Article
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 3, p. 293, doi. 10.1001/jamaneurol.2020.4857
- By:
- Publication type:
- Article
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 9, p. 1099, doi. 10.1001/jamaneurol.2020.1840
- By:
- Publication type:
- Article
Down Syndrome in a New Era for Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 22, p. 2157, doi. 10.1001/jama.2023.22924
- By:
- Publication type:
- Article
Advances in Alzheimer's Disease Drug Development.
- Published in:
- BMC Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12916-015-0297-4
- By:
- Publication type:
- Article
Advances in Alzheimer's disease drug development.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Recent developments in Alzheimer's disease therapeutics.
- Published in:
- BMC Medicine, 2009, v. 7, p. 1, doi. 10.1186/1741-7015-7-7
- By:
- Publication type:
- Article
Biglycan binds to α- and γ-sarcoglycan and regulates their expression during development.
- Published in:
- Journal of Cellular Physiology, 2006, v. 209, n. 2, p. 439, doi. 10.1002/jcp.20740
- By:
- Publication type:
- Article
Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS.
- Published in:
- FASEB Journal, 2006, v. 20, n. 10, p. 1724, doi. 10.1096/fj.05-5124fje
- By:
- Publication type:
- Article
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer's Disease.
- Published in:
- CNS Drugs, 2023, v. 37, n. 8, p. 671, doi. 10.1007/s40263-023-01021-8
- By:
- Publication type:
- Article
Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials.
- Published in:
- CNS Drugs, 2020, v. 34, n. 8, p. 785, doi. 10.1007/s40263-020-00740-6
- By:
- Publication type:
- Article
Alzheimer's Disease Clinical Trials: Moving Toward Successful Prevention.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Improving Memory and Cognition in Individuals with Down Syndrome.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder.
- Published in:
- American Journal of Medical Genetics. Part A, 2024, v. 194, n. 5, p. 1, doi. 10.1002/ajmg.a.63524
- By:
- Publication type:
- Article
Adverse childhood experiences and the development of Down syndrome regression disorder.
- Published in:
- American Journal of Medical Genetics. Part A, 2023, v. 191, n. 7, p. 1769, doi. 10.1002/ajmg.a.63199
- By:
- Publication type:
- Article
Functional Brain Imaging in the Clinical Assessment of Consciousness.
- Published in:
- 2010
- By:
- Publication type:
- Essay
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2019, v. 76, n. 10, p. 1219, doi. 10.1001/jamaneurol.2019.2050
- By:
- Publication type:
- Article
Prevalence and Severity of Alzheimer Disease in Individuals With Down Syndrome.
- Published in:
- 2019
- By:
- Publication type:
- Opinion
Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 7, p. 834, doi. 10.1001/jamaneurol.2018.0233
- By:
- Publication type:
- Article
Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.724969
- By:
- Publication type:
- Article
Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1214, doi. 10.1002/alz.13542
- By:
- Publication type:
- Article